[HTML][HTML] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang, HJ Chen… - British journal of …, 2017 - nature.com
Background: A phase III trial was conducted to compare the safety and efficacy of erlotinib
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang… - British journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background A phase III trial was conducted to compare the safety and efficacy of erlotinib
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations.
JJ Yang, Q Zhou, HH Yan, XC Zhang… - British Journal of …, 2017 - europepmc.org
Background A phase III trial was conducted to compare the safety and efficacy of erlotinib
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
[引用][C] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang, HJ Chen… - British Journal of …, 2017 - cir.nii.ac.jp
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung
cancer with EGFR mutations | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
cancer with EGFR mutations | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[HTML][HTML] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang… - British Journal of …, 2017 - ncbi.nlm.nih.gov
Background: A phase III trial was conducted to compare the safety and efficacy of erlotinib
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations.
JJ Yang, Q Zhou, HH Yan, XC Zhang… - British Journal of …, 2017 - europepmc.org
Background A phase III trial was conducted to compare the safety and efficacy of erlotinib
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …
with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth …